Novozymes

company

About

Novozymes is the world leader in bioinnovation.

Details

Last Funding Type
IPO
Industries
Biotechnology,Innovation Management
Founded date
Jan 1, 2000
Number Of Employee
5001 - 10000
Operating Status
Active
Stock Symbol
cph:NZYM-B
Legal Name
Novozymes A/S

Novozymes is a world leader in bioinnovation. Novozymes works with its partners to innovate new solutions and rethink industries around the world. Novozymes' industrial enzymes, microorganisms, biopolymers, and other proteins allow its customers to achieve more efficient use of raw materials, reduce energy consumption, replace traditional chemicals with more sustainable alternatives, and offer higher-quality products. Novozymes rethinks everyday products every day.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Novozymes has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jun 28, 2002 from a IPO round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 28, 2002 IPO Detail

Investments

Number of Investments
Number of Lead Investments
3
0
Novozymes has made 3 investments. Their most recent investment was on Dec 9, 2018, when Plant Response raised $6.90M.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 9, 2018 Plant Response
Series B $6.90M Agriculture
Nov 26, 2015 Plant Response
Series A $6.60M Agriculture
Nov 1, 2014 AgBiome
Series Unknown $17.50M Agriculture

Employee Profiles

Number of Employee Profiles
23
Novozymes has 23 current employee profiles, including Board member David A. Hogsett
Board member
Board member
Executive
Board member
Executive

Exits

Novozymes has had 1 exits. Novozymes most notable exits include Plant Response

Date Company Name Exit Type Industry
Feb 25, 2022 Plant Response M&A Agriculture Detail

Acquisition

Novozymes has acquired 16 organizations. Their most recent acquisition was Sybron Biochemicals on Jul 1, 2001. They acquired Sybron Biochemicals for 0.

Date Company Name
Industry Acquisition Type Price
Biotechnology acquisition Detail
Biotechnology acquisition Detail
Biotechnology acquisition Detail
Biotechnology acquisition Detail
Oct 31, 2007 Philom Bios
Biotechnology acquisition Detail